{
    "2018-11-09": [
        [
            {
                "time": "2018-10-31",
                "original_text": "Catalyst (CPRX) Reports Q3 Loss as Expected & Pipeline Update",
                "features": {
                    "keywords": [
                        "Q3 Loss",
                        "Expected",
                        "Pipeline Update"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-10-31",
                "original_text": "Keryx's (KERX) Loss Narrower Than Expected in Q3, Sales Lag",
                "features": {
                    "keywords": [
                        "Loss Narrower",
                        "Expected",
                        "Sales Lag"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-10-31",
                "original_text": "Keryx's (KERX) Loss Narrower Than Expected in Q3, Sales Lag",
                "features": {
                    "keywords": [
                        "Loss Narrower",
                        "Expected",
                        "Sales Lag"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-10-31",
                "original_text": "Celldex (CLDX) Q3 Earnings Beat Estimates, Revenues Miss",
                "features": {
                    "keywords": [
                        "Q3 Earnings",
                        "Beat Estimates",
                        "Revenues Miss"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-10-31",
                "original_text": "See what the IHS Markit Score report has to say about Eli Lilly And Co.",
                "features": {
                    "keywords": [
                        "IHS Markit Score",
                        "Eli Lilly"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-10-31",
                "original_text": "Pharma Stock Roundup: LLY, AZN Report Q3 Earnings, PFE Gets FDA Nod for Cancer Drug",
                "features": {
                    "keywords": [
                        "Pharma Stock",
                        "Q3 Earnings",
                        "FDA Nod",
                        "Cancer Drug"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}